Novacyt S.A. (Novacyt, the Company or the Group): Trading Up

Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces a trading update for the half year ended 30 June 2022 and provides an update

Related Keywords

France , Foster Mitchell Alex Shaw , Matthew Johnson Charlie Bouverat , James Mccarthy , David Allmond , Freddie Barnfield Duncan Monteith , Vadim Alexandre Rob Rees , Novacyt Pathflow , Durgetto Yannick Petit , Numis Securities Limited Joint Broker , Sp Angel Corporate Finance , Novacyt Group , Consulting International , Regulatory News , Microgen Bioproducts , Antigen Self Test , Chief Executive Officer , Chief Financial Officer , Nominated Adviser , Johnson Charlie Bouverat , Corporate Finance , Alexandre Rob Rees , Corporate Broking , Securities Limited , Joint Broker , Black Freddie Barnfield Duncan Monteith , French Listing Sponsor , Novacyt , Company , Group , Trading , Update , Progress , Against , Strategy , 022 ,